Raymond James Trust’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$686K Sell
96,637
-131,067
-58% -$836K 0.01% 640
2024
Q2
$1.3M Buy
227,704
+37,543
+20% +$239K 0.03% 413
2024
Q1
$1.41M Buy
190,161
+7,681
+4% +$64.1K 0.03% 385
2023
Q4
$1.69M Sell
182,480
-1,616
-0.9% -$11.9K 0.04% 334
2023
Q3
$1.24M Buy
184,096
+30,866
+20% +$246K 0.04% 365
2023
Q2
$1.46M Buy
153,230
+26,707
+21% +$226K 0.04% 333
2023
Q1
$1.19M Sell
126,523
-2,321
-2% -$23.9K 0.04% 375
2022
Q4
$1.07M Buy
128,844
+46,863
+57% +$440K 0.04% 383
2022
Q3
$770K Buy
81,981
+33,248
+68% +$421K 0.03% 438
2022
Q2
$675K Buy
48,733
+13,470
+38% +$201K 0.02% 484
2022
Q1
$591K Buy
+35,263
New +$585K 0.02% 567

Other funds holding CLVT

Raymond James Trust's CLVT Position: Q3 2024 in Review

Raymond James Trust reduced its Clarivate (CLVT) stake by 58% in Q3 2024, selling an estimated $836K and leaving 96,637 shares worth $686K. The position accounts for 0.01% of the portfolio, ranked #640.

Raymond James Trust first reported a position in CLVT in Q1 2022 and has held it in 11 quarters since. The position peaked at $1.69M in Q4 2023. 202 funds tracked by Wall St. Rank hold CLVT as of Q3 2024.

  • Raymond James Trust held 96,637 shares of Clarivate worth $686K as of Q3 2024.
  • Raymond James Trust sold 131,067 Clarivate shares in Q3 2024, an estimated $836K.
  • Clarivate made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #640 holding.
  • Raymond James Trust first reported a position in Clarivate in Q1 2022 and has held it in 11 quarters since.
  • Raymond James Trust's Clarivate position peaked at $1.69M in Q4 2023.
  • 202 funds tracked by Wall St. Rank held Clarivate as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.